for decades, but the innovative new neurotoxin Daxxify might be changing that. The injectable, which is often shortened to “Daxi" in aesthetic-lingo, is the most recent neuromodulator to have been approved by the U.S.
Food and Drug Administration (FDA) for the treatment of wrinkles. “There are now five FDA-approved neuromodulators for aesthetic treatments: Botox, Dysport, Daxxify, Xeomin, and Jeuveau,” MD, board-certified plastic surgeon at , tells Glamour.
That said, while every injectable currently available use the same type of toxin—botulinum toxin type A—Shridharani asserts that Daxxify differs from its predecessors.“We say Daxxify is the first real true innovation in neurotoxin because of its peptide exchange technology, which pretty much means it's a formulation,” Shridharani explains. "The formula for it doesn't have any human albumin or animal proteins, and so just by the way that it works, it tends to stay tightly bound and last longer at that neuromuscular junction.
It's really a big innovation and change in the neuromodulator world that allows for it to then last longer.” The fact that Daxxify injections last longer than Botox plays a huge part in its increasing popularity, especially since so many injectors and patients have noticed over the past few years.Intrigued?
Read more on glamour.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.